Advertisement
Screener

VERTEX PHARMACEUTICALS INC / MA (VRTX) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$546.89(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$546.89High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2026-08-04VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$470.72$617.00+31.08%Overweight
2026-05-05VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$429.85$615.00+43.07%Overweight
2026-02-13VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$465.02$607.00+30.53%Overweight
2026-01-27VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$468.41$606.00+29.37%Overweight
2025-11-04VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$426.00$414.00-2.82%Equal Weight
2025-08-05VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$472.27$408.00-13.61%Equal Weight
2025-05-06VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$500.19$499.00-0.24%Equal Weight
2025-02-10VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$469.97$467.00-0.63%Equal Weight
2025-01-30VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$438.40$435.00-0.78%Equal Weight
2024-12-19VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$396.64$418.00+5.39%Equal Weight
2024-08-05VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$494.46$509.00+2.94%Equal Weight
2024-02-06VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$428.89$472.00+10.05%Overweight
2023-12-14VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$406.60$446.00+9.69%Overweight
2023-12-08VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$350.15$415.00+18.52%Overweight
2023-11-06VRTX
VERTEX PHARMACEUTICALS INC / MA
Eliana Merle, CFABarclays$385.76$408.00+5.77%Overweight

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64